PT83073B - Processo para a preparacao de novos derivados da guanina - Google Patents

Processo para a preparacao de novos derivados da guanina

Info

Publication number
PT83073B
PT83073B PT83073A PT8307386A PT83073B PT 83073 B PT83073 B PT 83073B PT 83073 A PT83073 A PT 83073A PT 8307386 A PT8307386 A PT 8307386A PT 83073 B PT83073 B PT 83073B
Authority
PT
Portugal
Prior art keywords
derivatives
preparation
new guinea
guinea
new
Prior art date
Application number
PT83073A
Other languages
English (en)
Other versions
PT83073A (en
Inventor
Michael Raymond Harnden
Graham Richard Geen
Richard Lewis Jarvest
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858519011A external-priority patent/GB8519011D0/en
Priority claimed from GB858530491A external-priority patent/GB8530491D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of PT83073A publication Critical patent/PT83073A/pt
Publication of PT83073B publication Critical patent/PT83073B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT83073A 1985-07-27 1986-07-28 Processo para a preparacao de novos derivados da guanina PT83073B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858519011A GB8519011D0 (en) 1985-07-27 1985-07-27 Chemical compound
GB858530491A GB8530491D0 (en) 1985-12-11 1985-12-11 Chemical compound

Publications (2)

Publication Number Publication Date
PT83073A PT83073A (en) 1986-08-01
PT83073B true PT83073B (pt) 1989-02-28

Family

ID=26289562

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83073A PT83073B (pt) 1985-07-27 1986-07-28 Processo para a preparacao de novos derivados da guanina

Country Status (13)

Country Link
US (1) US4942166A (pt)
EP (1) EP0216459B1 (pt)
JP (1) JPH0670057B2 (pt)
AU (1) AU596366B2 (pt)
CA (1) CA1262132A (pt)
DE (1) DE3671227D1 (pt)
DK (1) DK167925B1 (pt)
ES (1) ES2000759A6 (pt)
GR (1) GR861963B (pt)
IE (1) IE58639B1 (pt)
MX (1) MX165149B (pt)
NZ (1) NZ216978A (pt)
PT (1) PT83073B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
US6207650B1 (en) * 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
GB8922076D0 (en) * 1989-09-28 1989-11-15 Beecham Group Plc Novel process
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
US5674869A (en) * 1990-07-07 1997-10-07 Beecham Group Plc Pharmaceutical treatment
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5670506A (en) * 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9323404D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
US6683084B1 (en) 1993-11-12 2004-01-27 Novartis International Pharmaceutical Ltd. Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
GB9323403D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9504497D0 (en) * 1995-03-07 1995-04-26 Smithkline Beecham Plc Pharmaceuticals
GB9615276D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
AT412211B (de) * 1996-07-20 2004-11-25 Novartis Int Pharm Ltd Verfahren zur herstellung von penciclovir und famciclovir
GB9615253D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
US6824793B1 (en) 1998-06-01 2004-11-30 Chiron Corporation Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
US6107303A (en) * 1999-03-15 2000-08-22 Demarco; Charlene C. Treatment of Epstein Barr infection
AU2003268213A1 (en) * 2002-08-26 2004-03-11 Teva Pharmaceutical Industries Ltd. Crystalline solid famciclovir forms i, ii, iii and preparation thereof
AU2006230269A1 (en) 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
CN111377926B (zh) * 2018-12-29 2024-06-07 凯默斯医药科技(上海)有限公司 一种喷昔洛韦晶型及其制备方法
CN110627793B (zh) * 2019-09-10 2020-08-28 天津理工大学 一种喷昔洛韦与3,5-二羟基苯甲酸共晶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU577303B2 (en) * 1983-08-18 1988-09-22 Novartis International Pharmaceutical Ltd 9-substituted-2-amino purines
EP0141927B1 (en) 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
DE3571810D1 (en) * 1984-01-26 1989-08-31 Merck & Co Inc Substituted butyl guanines and their utilization in antiviral compositions
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine

Also Published As

Publication number Publication date
CA1262132A (en) 1989-10-03
ES2000759A6 (es) 1988-03-16
DK356686D0 (da) 1986-07-25
MX165149B (es) 1992-10-28
US4942166A (en) 1990-07-17
IE861984L (en) 1987-01-27
DE3671227D1 (de) 1990-06-21
AU6055786A (en) 1987-01-29
PT83073A (en) 1986-08-01
JPS6236381A (ja) 1987-02-17
EP0216459B1 (en) 1990-05-16
IE58639B1 (en) 1993-10-20
DK167925B1 (da) 1994-01-03
JPH0670057B2 (ja) 1994-09-07
GR861963B (en) 1986-11-26
DK356686A (da) 1987-01-28
AU596366B2 (en) 1990-05-03
EP0216459A1 (en) 1987-04-01
NZ216978A (en) 1990-01-29

Similar Documents

Publication Publication Date Title
PT81859B (pt) Processo para a preparacao de derivados de tiazolidinodionas
PT83073B (pt) Processo para a preparacao de novos derivados da guanina
PT83179B (pt) Processo para a preparacao de carbinois aril-piperidinicos
PT81463B (pt) Processo para a preparacao de novos derivados 5-amino-4-hidroxivalerilo
PT82890B (pt) Processo para a preparacao de novos derivados de n-aralquil-piperidinametanol
BR8605084A (pt) Processo para a preparacao de diaminocompostos aromaticos
PT80270B (pt) Processo para a preparacao de derivados da 9a-aza-9a-homoeritromicina
PT80708B (pt) Processo aperfeicoado para a preparacao de derivados de benzenossulfonamida
PT84561B (pt) Processo aperfeicoado para a preparacao de derivados macrolidos
PT89780A (pt) Processo para a preparacao de derivados da tetrahidroisoquinolina
PT89922A (pt) Processo para a preparacao de derivados da tiazolidenodiona
PT83344A (pt) Processo para a preparacao de ypsilon-carbolinas antipsicoticas
PT89545A (pt) Processo para a preparacao de derivados da isoquinolinona
PT84010B (pt) Processo para a preparacao de derivados de pirimidina
PT88180A (pt) Processo para a preparacao de derivados alquilaminoalcoxifenilo
PT82445B (pt) Processo para a preparacao de novos derivados glicopeptidicos
PT89775A (pt) Processo para a preparacao de derivados de isoquinolina
PT80264B (pt) Processo para a preparacao de derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
PT91027A (pt) Processo para a preparacao de derivados peptidicos
PT92539A (pt) Processo para a preparacao de derivados de anfotericina b
PT82245B (pt) Processo para a preparacao de 2-amino-6-cloropurina
PT85608A (pt) Processo para a preparacao de derivados de fenil-etanolamina
PT83154B (pt) Processo para a preparacao de quinolizino-sulfonamidas
PT82712B (pt) Processo para a preparacao de novos derivados de quinolina
PT83531B (pt) Processo para a preparacao de derivados de dicloroanilina

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 20011115 NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. BM

TE3A Change of address (patent)

Owner name: BEECHAM GROUP P.L.C.

Effective date: 20011115